A collaborative multidisciplinary team
The research team Epilogy, Epidemiology and Evaluation of Therapeutics in Dermatology and Immune-Mediated Inflammatory Diseases is structured around a multidisciplinary core of drug-specialist physicians, clinicians (rheumatologists, dermatologists, internal medicine specialists), pharmacists, epidemiologists, methodologists, and biostatisticians collaborating on translational and population-based research projects.
The team also hosts post-doctoral researchers, PhD candidates, Master 2 (M2) students, and trainees involved in research activities spanning epidemiology, therapeutic evaluation, pharmaco-epidemiology, and public health in dermatology and immune-mediated inflammatory diseases.
This multidisciplinary organization promotes large-scale health data analysis, methodological innovation, and collaborative clinical research, with a focus on treatment effectiveness and safety, disease outcomes, and evidence generation to support clinical practice, public health decision-making, and improved patient care.
Leadership
Research activity focused on evaluating therapies for patients with psoriasis and other skin inflammatory disorders.
Head of the Psoriasis Research Group (GrPso) board.
Director of the Epilogy research unit.
Research interests focus on systematic review, meta-analysis and meta-research in dermatology.
Director of the Cochrane Skin Group.
Co-director of the Epilogy team.
Researchers – Team Council
Research focuses on systematic reviews, meta-analyses and meta-research in dermatology.
Methodologist of the Cochrane Skin Group.
Research focuses on epidemiology, prognosis and treatment of rare dermatological diseases.
Research focuses on meta-research in dermatology and autoimmune skin disorders.
Research focuses on psoriasis and skin cancer.
Clinical work focuses on chronic inflammatory rheumatism and targeted treatments.
Deputy Director of Epiphare.
Research focuses on environmental and social epidemiology applied to chronic diseases.
Research focuses on outcome measures and patient-reported outcomes in inflammatory diseases.
Research focuses on pharmaco-epidemiology of chronic inflammatory disorders.
Research focuses on severe skin infections.
Head of reference center TOXIBUL.
Head of the European ToxiTEN group within ERN-Skin.
Referring physician at the autoimmune competence center (MALIBUL).
Research focuses on drug adverse effects and pharmacovigilance.
Research focuses on medication risk prevention.
Research focuses on pharmacoepidemiology of inflammatory skin disorders.
Research focuses on meta-research in dermatology.
Research focuses on pharmacoepidemiology of inflammatory skin disorders.
Research focuses on drug delivery and treatment optimization.
Research focuses on pharmaco-epidemiology.
Research focuses on chronic inflammatory rheumatic diseases.
Research focuses on evaluation of health interventions.
Research focuses on statistical methods for causal inference.
Biostatisticians

Post-Doc



PhD







Administrative Officer

